Involvement of intestinal P-glycoprotein in the restricted absorption of methylprednisolone from rat small intestine

被引:60
作者
Saitoh, H [1 ]
Hatakeyama, M [1 ]
Eguchi, O [1 ]
Oda, M [1 ]
Takada, M [1 ]
机构
[1] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Pharmaceut, Ishikari, Hokkaido 06102, Japan
关键词
D O I
10.1021/js970163u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The interaction between steroid hormones and intestinal P-glycoprotein was investigated by measuring intestinal absorption from rat small intestine in situ. Prednisolone and hydrocortisone were rapidly absorbed from the entire small intestine. In contrast, methylprednisolone absorption was significantly retarded in jejunum and ileum by an intestinal efflux system. In the presence of verapamil an quinidine, the retarded absorption of methylprednisolone was completely recovered, suggesting that P-glycoprotein is responsible for the unique features of methylprednisolone absorption. A requisite for the substrate of intestinal P-glycoprotein seemed to be Ga-methyl group in the steroid structure. Substrate specificity of intestinal P-glycoprotein to steroid hormones was shown to be in part different from those in other tissues such as adrenal gland. Little of all three steroid hormones disappeared in the supernatant of mucosal homogenate from rat small intestine, indicating that intestinal metabolism of these steroid hormones was relatively small.
引用
收藏
页码:73 / 75
页数:3
相关论文
共 23 条
[1]   Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonist [J].
Aungst, BJ ;
Saitoh, H .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :114-119
[2]   CLASSICAL AND NOVEL FORMS OF MULTIDRUG-RESISTANCE AND THE PHYSIOLOGICAL FUNCTIONS OF P-GLYCOPROTEINS IN MAMMALS [J].
BORST, P ;
SCHINKEL, AH ;
SMIT, JJM ;
WAGENAAR, E ;
VANDEEMTER, L ;
SMITH, AJ ;
EIJDEMS, EWHM ;
BAAS, F ;
ZAMAN, GJR .
PHARMACOLOGY & THERAPEUTICS, 1993, 60 (02) :289-299
[3]   GLUCOCORTICOSTEROID THERAPY - MECHANISMS OF ACTION AND CLINICAL CONSIDERATIONS [J].
FAUCI, AS ;
DALE, DC ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (03) :304-315
[4]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[5]   BIOAVAILABILITY ASSESSMENT OF A LIQUID PREDNISONE PREPARATION [J].
GEORGITIS, JW ;
FLESHER, KA ;
SZEFLER, SJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1982, 70 (04) :243-247
[6]   MONITORING GLUCOCORTICOID THERAPY - A PHARMACOKINETIC APPROACH [J].
HILL, MR ;
SZEFLER, SJ ;
BALL, BD ;
BARTOSZEK, M ;
BRENNER, AM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) :390-398
[7]   THE FUNCTION OF GP170, THE MULTIDRUG-RESISTANCE GENE-PRODUCT, IN THE BRUSH-BORDER OF RAT INTESTINAL-MUCOSA [J].
HSING, S ;
GATMAITAN, Z ;
ARIAS, IM .
GASTROENTEROLOGY, 1992, 102 (03) :879-885
[8]   SURFACE GLYCOPROTEIN MODULATING DRUG PERMEABILITY IN CHINESE-HAMSTER OVARY CELL MUTANTS [J].
JULIANO, RL ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 455 (01) :152-162
[9]   DISPOSITION OF METHYLPREDNISOLONE AND ITS SODIUM SUCCINATE PRODRUG INVIVO AND IN PERFUSED LIVER OF RATS - NONLINEAR AND SEQUENTIAL 1ST-PASS ELIMINATION [J].
KONG, AN ;
JUSKO, WJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (05) :409-415
[10]  
LEVINE RR, 1961, J PHARMACOL EXP THER, V131, P319